Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production

Producción científica: Articlerevisión exhaustiva

230 Citas (Scopus)

Resumen

In Alzheimer's disease (AD), chronically activated glia contribute to neuronal dysfunction through production of neuroinflammatory molecules like interleukin (IL)-1β. As a first step to address the signaling pathways important for pro-inflammatory cytokine induction, and whether different activators use distinct pathways, we tested the involvement of mitogen-activated protein kinase (MAPK) pathways in microglial IL-1β production. Microglial cultures stimulated with lipopolysaccharide, S100B, or beta-amyloid showed rapid activation of three different MAPKs (p38, ERK1/2, and JNK) and a later increase in IL-1β levels, consistent with a possible mechanistic relationship between MAPK and IL-1β. To more directly test this possibility, we stimulated microglia in the presence of selective MAPK inhibitors, and found that inhibition of each of the three MAPK pathways inhibited IL-1β production in a concentration-dependent manner. In addition, the relative importance of each MAPK to IL-1β production depended on the activating stimulus. These data demonstrate that MAPK pathways are important for microglial IL-1β production, and suggest that different glial activators use distinct sets of signaling pathways to induce the same disease-relevant end-point in microglia.

Idioma originalEnglish
Páginas (desde-hasta)431-439
Número de páginas9
PublicaciónNeurobiology of Aging
Volumen25
N.º4
DOI
EstadoPublished - abr 2004

Nota bibliográfica

Funding Information:
These studies were supported in part by NIH grants R37 AG13939, R01 AG20243, and P01 AG21184. S.H.K. is a postdoctoral scholar in the Drug Discovery Training Program supported by NIH grant T32 AG00260.

Financiación

These studies were supported in part by NIH grants R37 AG13939, R01 AG20243, and P01 AG21184. S.H.K. is a postdoctoral scholar in the Drug Discovery Training Program supported by NIH grant T32 AG00260.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)P01 AG21184, R01 AG20243, R37 AG13939
National Institute on AgingT32AG000260

    ASJC Scopus subject areas

    • General Neuroscience
    • Aging
    • Clinical Neurology
    • Developmental Biology
    • Geriatrics and Gerontology

    Huella

    Profundice en los temas de investigación de 'Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production'. En conjunto forman una huella única.

    Citar esto